<?xml version='1.0'?><!DOCTYPE Annotation PUBLIC "//GENIA//DTD GENIA ANNOTATION EVENT 2.0//EN_Modified" "../ModifiedGENIAtypes/Modified_GENIA_event_20.dtd"><Annotation annotates="http://www.ncbi.nlm.nih.gov/entrez/eutils/efetch.fcgi?db=pubmed&amp;retmode=xml&amp;rettype=medline&amp;id=10440930" created="06/07/2006" creator="Noriko Katsu"><PubmedArticleSet><PubmedArticle><MedlineCitation>
<PMID>10440930</PMID>
<Article>
<ArticleTitle>
<sentence id="S1">Suppression of <term id="T1" lex="TNFalpha-mediated_NFkappaB_activity" sem="Other"><term id="T2" lex="TNFalpha" sem="Protein_molecule">TNFalpha</term>-mediated <term id="T3" lex="NFkappaB" sem="Protein_complex">NFkappaB</term> activity</term> by <term id="T4" lex="myricetin" sem="Organic_compound_other">myricetin</term> and other <term id="T5" lex="flavonoid" sem="Organic_compound_other">flavonoids</term> through downregulating the activity of <term id="T6" lex="IKK" sem="Protein_molecule">IKK</term> in <term id="T7" lex="ECV304_cell" sem="Cell_cultured">ECV304 cells</term>.</sentence>
<event KT="Investigation" id="E1">
<type class="Negative_regulation"/>
<theme idref="E5"/>
<cause idref="E2"/>
<clue><clueType>Suppression</clueType> <linkTheme>of</linkTheme> TNFalpha-mediated NFkappaB activity by myricetin and other flavonoids <linkCause>through</linkCause> downregulating the activity of IKK <clueLoc>in ECV304 cells</clueLoc>.</clue>
</event>
<event KT="Other" id="E2">
<type class="Negative_regulation"/>
<theme idref="T6"/>
<cause idref="T4"/>
<clue>Suppression of TNFalpha-mediated NFkappaB activity <linkCause>by</linkCause> myricetin and other flavonoids through <clueType>downregulating</clueType> the activity <linkTheme>of</linkTheme> IKK <clueLoc>in ECV304 cells</clueLoc>.</clue>
</event>
<event KT="Investigation" id="E3">
<type class="Negative_regulation"/>
<theme idref="E5"/>
<cause idref="E4"/>
<clue><clueType>Suppression</clueType> <linkTheme>of</linkTheme> TNFalpha-mediated NFkappaB activity by myricetin and other flavonoids <linkCause>through</linkCause> downregulating the activity of IKK <clueLoc>in ECV304 cells</clueLoc>.</clue>
</event>
<event KT="Other" id="E4">
<type class="Negative_regulation"/>
<theme idref="T6"/>
<cause idref="T5"/>
<clue>Suppression of TNFalpha-mediated NFkappaB activity <linkCause>by</linkCause> myricetin and other flavonoids through <clueType>downregulating</clueType> the activity <linkTheme>of</linkTheme> IKK <clueLoc>in ECV304 cells</clueLoc>.</clue>
</event>
<event KT="Other" id="E5">
<type class="Positive_regulation"/>
<theme idref="T3"/>
<cause idref="T2"/>
<clue>Suppression of TNFalpha-<clueType>mediated</clueType> NFkappaB activity by myricetin and other flavonoids through downregulating the activity of IKK in ECV304 cells.</clue>
</event>
</ArticleTitle>
<Abstract>
<AbstractText>
<sentence id="S2"><term id="T8" lex="flavonoid" sem="Organic_compound_other">Flavonoids</term> are a group of <term id="T9" lex="naturally-occurring_phenolic_compound" sem="Organic_compound_other">naturally-occurring phenolic compounds</term> in the plant kingdom, and many <term id="T10" lex="flavonoid" sem="Organic_compound_other">flavonoids</term> are found with <term id="T11" lex="vascular_protective_propertie" sem="Other"><term id="A1" sem="Body_region">vascular</term> protective properties</term>.</sentence>
<event KT="Fact" id="E6">
<type class="Biological_process"/>
<theme idref="A1"/>
<cause idref="T10"/>
<clue>Flavonoids are a group of naturally-occurring phenolic compounds in the plant kingdom, and many flavonoids are found with vascular <clueType>protective</clueType> properties.</clue>
</event>
<sentence id="S3">Nevertheless how the protective response is exerted by <term id="T12" lex="flavonoid" sem="Organic_compound_other">flavonoids</term> is not well characterized.</sentence>
<event KT="Fact" id="E7">
<type class="Biological_process"/>
<cause idref="T12"/>
<clue>Nevertheless how the <clueType>protective response</clueType> is exerted <linkCause>by</linkCause> flavonoids is not well characterized.</clue>
<comment>NO THEME</comment></event>
<sentence id="S4">In view of the <term id="T13" lex="nuclear_factor-kappaB" sem="Protein_complex">nuclear factor-kappaB</term> (<term id="T14" lex="NFkappaB" sem="Protein_complex">NFkappaB</term>) may play a central role in the initiation of <term id="T15" lex="atherosclerosis" sem="Other">atherosclerosis</term>, prevention of the activation of <term id="T16" lex="NFkappaB" sem="Protein_complex">NFkappaB</term> represents an important role in protecting <term id="T17" lex="vascular_injury" sem="Other"><term id="A2" sem="Body_region">vascular</term> injury</term>.</sentence>
<event CL="L1" KT="Analysis" id="E8" uncertainty="probable">
<type class="Regulation"/>
<theme idref="E9"/>
<cause idref="T14"/>
<clue>In view of the nuclear factor-kappaB (NFkappaB) <clueKT><clueCL>may</clueCL></clueKT> <clueType>play</clueType> a central <clueType>role</clueType> <linkTheme>in</linkTheme> the initiation of atherosclerosis, prevention of the activation of NFkappaB represents an important role in protecting vascular injury.</clue>
</event>
<event KT="Other" id="E9">
<type class="Physiological_process"/>
<theme idref="T15"/>
<clue>In view of the nuclear factor-kappaB (NFkappaB) may play a central role in the <clueType>initiation</clueType> <linkTheme>of</linkTheme> atherosclerosis, prevention of the activation of NFkappaB represents an important role in protecting vascular injury.</clue>
</event>
<event KT="Other" id="E10">
<type class="Negative_regulation"/>
<theme idref="E11"/>
<clue>In view of the nuclear factor-kappaB (NFkappaB) may play a central role in the initiation of atherosclerosis, <clueType>prevention</clueType> <linkTheme>of</linkTheme> the activation of NFkappaB represents an important role in protecting vascular injury.</clue>
</event>
<event KT="Other" id="E11">
<type class="Positive_regulation"/>
<theme idref="T16"/>
<clue>In view of the nuclear factor-kappaB (NFkappaB) may play a central role in the initiation of atherosclerosis, prevention of the <clueType>activation</clueType> <linkTheme>of</linkTheme> NFkappaB represents an important role in protecting vascular injury.</clue>
</event>
<event KT="Fact" id="E12">
<type class="Regulation"/>
<theme idref="E13"/>
<cause idref="E10"/>
<clue>In view of the nuclear factor-kappaB (NFkappaB) may play a central role in the initiation of atherosclerosis, prevention of the activation of NFkappaB <clueType>represents</clueType> an important <clueType>role</clueType> <linkTheme>in</linkTheme> protecting vascular injury.</clue>
</event>
<event KT="Other" id="E13">
<type class="Negative_regulation"/>
<theme idref="A2"/>
<clue>In view of the nuclear factor-kappaB (NFkappaB) may play a central role in the initiation of atherosclerosis, prevention of the activation of NFkappaB represents an important role in <clueType>protecting</clueType> vascular <clueType>injury</clueType>.</clue>
</event>
<sentence id="S5">In this study, the effects of <term id="T18" lex="flavonoid" sem="Organic_compound_other">flavonoids</term> on <term id="T19" lex="NFkappaB/inhibitor-kappaB_(IkappaB)_system" sem="Other"><term id="T20" lex="NFkappaB" sem="Protein_complex">NFkappaB</term>/inhibitor-kappaB (<term id="T21" lex="IkappaB" sem="Protein_molecule">IkappaB</term>) system</term> in <term id="T22" lex="ECV304_cell" sem="Cell_cultured">ECV304 cells</term> activated with <term id="T23" lex="tumor_necrosis_factor-alpha" sem="Protein_molecule">tumor necrosis factor-alpha</term> (<term id="T24" lex="TNFalpha" sem="Protein_molecule">TNFalpha</term>) were examined.</sentence>
<event KT="Investigation" id="E14" uncertainty="doubtful">
<type class="Regulation"/>
<theme idref="E15"/>
<cause idref="T18"/>
<clue>In this study, the <clueType>effects</clueType> <linkCause>of</linkCause> flavonoids <linkTheme>on</linkTheme> NFkappaB/inhibitor-kappaB (IkappaB) system in ECV304 cells activated with tumor necrosis factor-alpha (TNFalpha) were <clueKT>examined</clueKT>.</clue>
</event>
<event KT="Other" id="E15">
<type class="Positive_regulation"/>
<theme idref="T19"/>
<cause idref="T24"/>
<clue>In this study, the effects of flavonoids on NFkappaB/inhibitor-kappaB (IkappaB) system <clueLoc>in ECV304 cells</clueLoc> <clueType>activated</clueType> <linkCause>with</linkCause> tumor necrosis factor-alpha (TNFalpha) were examined.</clue>
</event>
<sentence id="S6">We investigated the inhibitory action of six <term id="T25" lex="flavonoid" sem="Organic_compound_other">flavonoids</term> on <term id="T26" lex="IkappaB_kinase" sem="Protein_molecule">IkappaB kinase</term> (<term id="T27" lex="IKK" sem="Protein_molecule">IKK</term>) activity, an enzyme recently found to phosphorylate critical <term id="A109" sem="Amino_acid_monomer"><term id="T28" lex="serine" sem="Amino_acid_monomer">serine</term> residues</term> of <term id="A3" sem="Protein_molecule">IkappaB</term> for <term id="A4" sem="Other">degradation</term>.</sentence>
<event KT="Investigation" id="E16" uncertainty="doubtful">
<type class="Negative_regulation"/>
<theme idref="T27"/>
<cause idref="T25"/>
<clue>We <clueKT>investigated</clueKT> the <clueType>inhibitory action</clueType> <linkCause>of</linkCause> six flavonoids <linkTheme>on</linkTheme> IkappaB kinase (IKK) activity, an enzyme recently found to phosphorylate critical serine residues of IkappaB for degradation.</clue>
</event>
<event id="E17">
<type class="Protein_amino_acid_phosphorylation"/>
<theme idref="A3"/>
<site idref="A109"/>
<clue>We investigated the inhibitory action of six flavonoids on IkappaB kinase (IKK) activity, an enzyme recently found to <clueType>phosphorylate</clueType> critical serine residues <linkTheme>of</linkTheme> IkappaB for degradation.</clue>
</event>
<event Source="Other" id="E21">
<type class="Positive_regulation"/>
<theme idref="E17"/>
<cause idref="T27"/>
<clue>We investigated the inhibitory action of six flavonoids on IkappaB kinase (IKK) activity, an enzyme <clueSource>recently</clueSource> <clueKT>found</clueKT> to phosphorylate critical serine residues of IkappaB for degradation.</clue>
<comment>NO CLUETYPE</comment></event>
<event Manner="High" id="E18">
<type class="Positive_regulation"/>
<theme idref="A4"/>
<cause idref="E17"/>
<clue>We investigated the inhibitory action of six flavonoids on IkappaB kinase (IKK) activity, an enzyme recently found to phosphorylate <clueType><clueManner>critical</clueManner></clueType> serine residues of IkappaB <linkTheme>for</linkTheme> degradation.</clue>
</event>
<sentence id="S7">Of six <term id="T29" lex="flavonoid" sem="Organic_compound_other">flavonoids</term> tested, <term id="T30" lex="myricetin" sem="Organic_compound_other">myricetin</term> was found to strongly inhibit <term id="T31" lex="IKK" sem="Protein_molecule">IKK</term> kinase activity, and prevent the degradation of <term id="T32" lex="IkappaBalpha" sem="Protein_molecule">IkappaBalpha</term> and <term id="T33" lex="IkappaBbeta" sem="Protein_molecule">IkappaBbeta</term> in activated <term id="A5" sem="Cell_natural">endothelial cells</term>.</sentence>
<event Manner="High" id="E19">
<type class="Negative_regulation"/>
<theme idref="T31"/>
<cause idref="T30"/>
<clue>Of six flavonoids tested, myricetin was <clueKT>found</clueKT> to <clueManner>strongly</clueManner> <clueType>inhibit</clueType> IKK kinase activity, and prevent the degradation of IkappaBalpha and IkappaBbeta in activated endothelial cells.</clue>
</event>
<event id="E20">
<type class="Negative_regulation"/>
<theme idref="E23"/>
<cause idref="T30"/>
<clue>Of six flavonoids tested, myricetin was <clueKT>found</clueKT> to strongly inhibit IKK kinase activity, and <clueType>prevent</clueType> the degradation of IkappaBalpha and IkappaBbeta in activated endothelial cells.</clue>
</event>
<event id="E22">
<type class="Negative_regulation"/>
<theme idref="E24"/>
<cause idref="T30"/>
<clue>Of six flavonoids tested, myricetin was <clueKT>found</clueKT> to strongly inhibit IKK kinase activity, and <clueType>prevent</clueType> the degradation of IkappaBalpha and IkappaBbeta in activated endothelial cells.</clue>
</event>
<event KT="Other" id="E23">
<type class="Protein_catabolism"/>
<theme idref="T32"/>
<clue>Of six flavonoids tested, myricetin was found to strongly inhibit IKK kinase activity, and prevent the <clueType>degradation</clueType> <linkTheme>of</linkTheme> IkappaBalpha and IkappaBbeta <clueLoc>in activated endothelial cells</clueLoc>.</clue>
</event>
<event KT="Other" id="E24">
<type class="Protein_catabolism"/>
<theme idref="T33"/>
<clue>Of six flavonoids tested, myricetin was found to strongly inhibit IKK kinase activity, and prevent the <clueType>degradation</clueType> <linkTheme>of</linkTheme> IkappaBalpha and IkappaBbeta <clueLoc>in activated endothelial cells</clueLoc>.</clue>
</event>
<event id="E25">
<type class="Physiological_process"/>
<theme idref="A5"/>
<clue>Of six flavonoids tested, myricetin was found to strongly inhibit IKK kinase activity, and prevent the degradation of IkappaBalpha and IkappaBbeta in <clueType>activated</clueType> endothelial cells.</clue>
</event>
<sentence id="S8">Furthermore, <term id="T34" lex="myricetin" sem="Organic_compound_other">myricetin</term> was also found to inhibit <term id="T35" lex="NFkappaB" sem="Protein_complex">NFkappaB</term> activity correlated with suppression of <term id="A6" sem="Cell_natural">monocyte</term> adhesion to <term id="T36" lex="ECV304_cell" sem="Cell_cultured">ECV304 cells</term>.</sentence>
<event id="E26">
<type class="Negative_regulation"/>
<theme idref="T35"/>
<cause idref="T34"/>
<clue>Furthermore, myricetin was also <clueKT>found</clueKT> to <clueType>inhibit</clueType> NFkappaB activity correlated with suppression of monocyte adhesion to ECV304 cells.</clue>
</event>
<event KT="Other" id="E27">
<type class="Negative_regulation"/>
<theme idref="E28"/>
<clue>Furthermore, myricetin was also found to inhibit NFkappaB activity correlated with <clueType>suppression</clueType> <linkTheme>of</linkTheme> monocyte adhesion to ECV304 cells.</clue>
</event>
<event KT="Other" id="E28">
<type class="Cell_adhesion"/>
<theme idref="A6"/>
<theme idref="T36"/>
<clue>Furthermore, myricetin was also found to inhibit NFkappaB activity correlated with suppression of monocyte <clueType>adhesion</clueType> <linkTheme>to</linkTheme> ECV304 cells.</clue>
</event>
<event KT="Analysis" id="E29">
<type class="Correlation"/>
<theme idref="E26"/>
<theme idref="E27"/>
<clue>Furthermore, myricetin was also found to inhibit NFkappaB activity <clueType><clueKT>correlated</clueKT></clueType> <linkTheme>with</linkTheme> suppression of monocyte adhesion to ECV304 cells.</clue>
</event>
<sentence id="S9">Therefore we conclude that <term id="T37" lex="flavonoid" sem="Organic_compound_other">flavonoids</term> may be of therapeutic value for vascular disease through down regulation of <term id="T38" lex="NFkappaB/IkappaB_system" sem="Other"><term id="T39" lex="NFkappaB" sem="Protein_complex">NFkappaB</term><term id="T40" lex="IkappaB" sem="Protein_molecule">/IkappaB</term> system</term>.</sentence>
<event KT="Other" id="E30" uncertainty="probable">
<type class="Negative_regulation"/>
<theme idref="T38"/>
<cause idref="T37"/>
<clue>Therefore we conclude that flavonoids may be of therapeutic value for vascular disease through <clueType>down regulation</clueType> <linkTheme>of</linkTheme> NFkappaB/IkappaB system.</clue>
</event>
<sentence id="S10">Copyright 1999 Wiley-Liss, Inc.</sentence>
</AbstractText>
</Abstract></Article></MedlineCitation></PubmedArticle></PubmedArticleSet></Annotation>
